您的位置: 首页 > 农业专利 > 详情页

Large scale production process for capped and un-capped antibody cysteines and their use in therapeutic protein conjugation
专利权人:
Pfizer Inc.
发明人:
Dutta, Kaushik,Gomes, Jose Manuel,Kotch, Frank W.,Patel, Vimalkumar B.,Prashad, Amarnauth Shastrie,Procopio-Melino, Renee L.,Zhong, Xiaotian
申请号:
AU2018218548
公开号:
AU2018218548A1
申请日:
2018.02.01
申请国别(地区):
AU
年份:
2019
代理人:
摘要:
Optimizing production of selectively capped, and uncapped, cysteines on antibodies by manipulation of cell growth conditions including the deliberate depletion of cysteine and/or cystine in the cell culture process by way of media components, batch duration, or cell density to achieve efficient production of proteins including antibody-drug-conjugates (ADCs).; conjugating a TNB-capped cysteine-containing protein by reacting it with a reducing agent capable of detaching the TNB-capping moieties from the protein without significantly reducing antibody inter-chain sulfur bonds, and conjugating reduced sulfur bonds on the protein to a payload through a reactive linking moiety.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充